Sartorius Stedim Biotech S.A. (SDMHF)
OTCMKTS · Delayed Price · Currency is USD
204.24
-2.01 (-0.97%)
Sep 16, 2025, 9:59 AM EDT
Sartorius Stedim Biotech Market Cap
Sartorius Stedim Biotech has a market cap or net worth of $20.20 billion as of September 16, 2025. Its market cap has increased by 4.63% in one year.
Market Cap
20.20B
Enterprise Value
22.93B
Revenue
3.40B
Ranking
n/a
PE Ratio
76.39
Stock Price
$204.24
Market Cap Chart
Since March 13, 2008, Sartorius Stedim Biotech's market cap has increased from 737.16M to 20.20B, an increase of 2,640.55%. That is a compound annual growth rate of 20.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 20.20B | 6.27% |
| Dec 31, 2024 | 19.01B | -22.08% |
| Dec 29, 2023 | 24.40B | -18.13% |
| Dec 30, 2022 | 29.80B | -41.07% |
| Dec 31, 2021 | 50.57B | 54.01% |
| Dec 31, 2020 | 32.84B | 114.91% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 789.71M |
| Tian'an Technology Group | 782.91M |
| Elite Pharmaceuticals | 750.21M |
| Glass House Brands | 566.73M |
| Northwest Biotherapeutics | 390.10M |
| CytoDyn | 359.27M |
| American Oncology Network | 353.52M |